Earlier Treatment of Kidney Disease Complication, Zemplar® Shows Potential in Phase III Trial
Wed, 04 May 2005 09:00 AM EST
... Abbott today presented the results of its pivotal Phase III clinical studies for Zemplar® (paricalcitol) Capsules in patients with stage three and four chronic kidney disease (CKD) who do not yet require dialysis... click link for more info. ...
Related Topics
- Clinical Trials
- Kidney Disease
- Polycystic Kidney Disease
- Kidney Diseases
- Kidney Cysts
- Kidney Cancer
- Kidney Stones
- Complications
- Infection (kidney)
- Crohn's Disease
- Antithrombin III
- Graves' Disease
- Diseases & Conditions
- Autoimmune Diseases
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Kidney Failure
- Rare Diseases
- Disease Prevention
- Periodontal Disease
- Kidney Disease in Children

Not Signed In -


